The 3849+10 kb C→T mutation in a 21-year-old patient with cystic fibrosis

Ear, Nose and Throat Journal

Volumn 75, Issue 12, 1996, Pages 793-795

  Kaplan, D M ^a,b,c   Niv, A ^a,b   Aviram, M ^a,b   Parvari, R ^a,b   Leiberman, A ^a,b   Fliss, D M ^a,b  

^a Ben Gurion University of the Negev ^*

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CEFAZOLIN; METRONIDAZOLE; STREPTOMYCIN;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CHRONIC SINUSITIS; CYSTIC FIBROSIS; EARLY DIAGNOSIS; FEMALE; GENE MUTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NOSE POLYP; PHENOTYPE; SWEAT TEST; TOPICAL DRUG ADMINISTRATION;

EID: 0030466375     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556139607501212     Document Type: Article

References (17)

1. McQuitty JC, Lewis NC. Cystic fibrosis, in Rudolph AM, Hoffman JIE, Rudolph CD (eds): Rudolph Pediatrics. Norwalk, Connecticut/San Mateo, California, Appleton & Lange 1991;27-33.
2. Kerem B, Rommens JM, Buchanan JA, et al. Identification of the Cystic Fibrosis gene: Genetic analysis. Science 1989; 1073-80.
3. Augarten A, Kerem BS, Yahav Y, et al. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849+10 kB C→T mutation. Lancet 1993; 342:24-5.
4. Kawasaki ES. Sample preparation from blood, cells and other fluids, in Innis MA, Gelfand DH, Sninski JJ, et al (eds): PCR protocols: A guide to methods and applications. San Diego, California, Academic Press, Inc. 1990;146-52.
5. Abeliovich D, Lavon IP, Lerer I, et al. Screening for five mutations detects 97% of cystic fibrosis chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. Am J Hum Genet 1992;51:951-6.
6. Shwachman H, Kulczycki LL, Mueller HL, et al. Nasal polyposis in patients with cystic fibrosis. Pediatrics 1962;30: 389-401.
7. Rulon JT, Brown HA, Logan GB. Nasal polyps and cystic fibrosis of the pancreas. Arch Otolaryngol 1963;78:192-9.
8. Stern RC, Boat TF, Wood RE, et al. Treatment and prognosis of nasal polyps in cystic fibrosis. Am J Dis Child 1982;136:1067-70.
9. Cepro R, Smith RJH, Caltin FI, et al. Cystic fibrosis - An otolaryngologic perspective. Otolaryngol Head and Neck Surg 1987;97:356-60.
10. Gharib R, Allen RP, Juus HA. Paranasal sinuses in cystic fibrosis: Incidence of roentgen abnormalities. Am J Dis Child 1964;108:499-502.
11. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989;245:1066-73.
12. Rommens JM, Iannuzzi MC, Kerem B, et al. Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 1989;245:1059-65.
13. Cystic Fibrosis Genetic Analysis Consortium. World wide survey of the ΔF508 mutation - Report from the Cystic Fibrosis Genetic Analysis Consortium. Am J Hum Genet 1990;47:354-9 (Letter).
14. Kerem E, Corey M, Kerem BS, et al. The relation between genotype and phenotype in cystic fibrosis - analysis of the most common mutation (ΔF508). N Eng J Med 1990;323:1517-22.
15. Santis G, Osborne L, Knight RA, et al. Linked marker haplotypes and the ΔF508 mutation in adults with mild pulmonary disease and cystic fibrosis. Lancet 1990;335:1426-9.
16. Shoshani T, Augarten A, Gazit E, et al. Association of nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet 1992;50:222-8.
17. Highsmith WE, Burch LH, Boat TF, et al. Identification of a homozygous point mutation in intron 19 in an inbred CF patient with a mild disease and normal sweat chloride: Creation of an alternative splice site resulting in base sequence insertion in CFTR coding region between exon 19 and 20. Pediatr Pulmonol Suppl 1991;6:22A.